YTHDF2 and colorectal carcinoma: METTL14 acts as an anti-oncogene in CRC, abolishing SOX4 mRNA stability and facilitating SOX4 mRNA degradation in a YTHDF2-dependent manner, preventing metastasis in CRC (Chen et al., 2020a).